Chemistry Reference
In-Depth Information
Hashimoto Y and Degawa M. Induction of cytochrome P450 isoforms by carcinogenic aro-
matic amines and carcinogenic susceptibility of rodent animals.
Pharmacogenetics
1995; 5: S80-83.
Haskard C, Binnion C, and Ahokas J. Factors affecting the sequestration of aflatoxin by
Lactobacillus rhamnosus
strain GG.
Chem Biol Interact
2000; 128: 39-49.
Helsby NA, Zhu S, Pearson AE, Tingle MD, and Ferguson LR. Antimutagenic effects of wheat
bran diet through modification of xenobiotic metabolising enzymes.
Mutat Res
2000;
454: 77-88.
Henry SH, Bosch FX, Troxell TC, and Bolger PM. Policy forum: Public health. Reducing liver
cancer—Global control of aflatoxin.
Science
1999; 286: 2453-54.
Hirayama K and Rafter J. The role of probiotic bacteria in cancer prevention.
Microbes Infect
2000; 2: 681-86.
Johnson IT, Williamson G, and Musk SRR. Anticarcinogenic factors in plant foods: A new
class of nutrients?
Nutr Res Rev
1994; 7: 175-204.
Joseph P and Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically
prevents the formation of benzo[
a
]pyrene quinone-DNA adducts generated by cyto-
chrome P4501A1 and P450 reductase.
Proc Natl Acad Sci U S A
1994; 91: 8413-17.
Kanazawa K, Konishi F, and Mitsuoka T. Factors influencing the development of sigmoid
colon cancer. Bacteriologic and biochemical studies.
Cancer
1996; 77: 1701-1706.
Kapila S. Studies on biodefensive properties of lactobacilli for their applications as probiotics.
Ph.D. thesis, NDRI (Deemed University), Karnal, India, 2004.
Kapila S, Vibha, and Sinha PR. Antioxidative and hypocholesterolemic effect of
Lactobacillus
casei
ssp
casei
(biodefensive properties of lactobacilli).
Indian J Med Sci
2006; 60:
361-70.
Khalili K, Croul S, DelValle L, Krynska B, and Gordon J. Oncogenic potential of human neu-
rotropic virus: Laboratory and clinical observations.
Isr Med Assoc J
2001; 3: 210.
Kirlin WG, Cai J, DeLong MJ, Patten EJ, and Jones DP. Dietary compounds that induce can-
cer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon
carcinoma cells.
J Nutr
1999; 129: 1827-35.
Kulkarni N and Reddy BS. Inhibitory effect of
Bifidobacterium longum
cultures on the
azoxymethane-induced aberrant crypt foci formation and faecal bacterial beta-glucuroni-
dase.
Proc Soc Exp Biol Med
1994; 207: 278-83.
Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, and Zimer M. Antioxidative
probiotic fermented goat's milk decreases oxidative stress mediated atherogenicity in
human subjects.
Br J Nutr
2003; 90: 449-56.
Lamprecht SA and Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and
folate: Molecular mechanisms.
Nat Rev Cancer
2003; 3: 601-14.
Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Maurer-Jensen M, and Kadlubar FF.
Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and puta-
tive exposure to food-borne heterocyclic amines increase the risk for colorectal cancer
or polyps.
Cancer Epidemiol Biomarkers Prev
1994; 3: 675-82.
Langman M and Boyle P. Chemoprevention of colorectal cancer.
Gut
1998; 43: 78-585.
Lee JW, Shin JG, Kim EH, Kang HE,Yim IB, Kim JY, Joo HG, and Woo HJ. Immunomodulatory
and antitumor effects
in-vivo
by the cytoplasmic fraction of
Lactobacillus casei
and
Bifidobacterium longum
.
J Vet Sci
2004; 5: 41-48.
Lhoste EF, Nugon-Baudon L, Lory S, Meslin JC, and Andrieux C. The fermentation of
lactulose in rats inoculated with
Clostridium paraputrificum
influences the activities
of liver and intestinal xenobiotic-metabolising enzymes.
J Sci Food Agric
2001; 81:
1397-1404.
